Sequent Scientific Limited — Investor Meet, 13-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

SeQuent and Viyash delivered strong Q1 FY26 performance. SeQuent's revenue grew 13% YoY to ₹441.4 Cr, with EBITDA up 24.7% to ₹60.2 Cr (13.6% margin). PAT surged 93.7% to ₹17.6 Cr. API revenue hit ₹105.4 Cr. Viyash reported ₹353 Cr revenue and ₹68 Cr EBITDA (19.5% margin). Combined EBITDA jumped 21% to ₹129 Cr (16.2% margin). The merger is on track, with NCLT meeting on August 30. Synergies in R&D, cost, and manufacturing are already contributing, fueling management's confidence in continued growth.